The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of drug-resistant immunotherapy (DRI) with gene-modified autologous γδ T cells in patients with newly diagnosed glioblastoma multiforme (GBM) receiving maintenance temozolomide (TMZ).
 
Louis B. Nabors
Consulting or Advisory Role - Chimerix
Patents, Royalties, Other Intellectual Property - Development of novel inhibitors to HuR through NCI funded peer reviewed research.
Other Relationship - cns pharmaceuticals; University of Pennsylvania
 
Mina Lobbous
No Relationships to Disclose
 
Lawrence S. Lamb
Employment - In8Bio
Leadership - In8Bio
Stock and Other Ownership Interests - In8Bio
Patents, Royalties, Other Intellectual Property - In8Bio
 
Kate Rochlin
Employment - In8Bio (I)
Leadership - In8Bio
Stock and Other Ownership Interests - In8Bio
Patents, Royalties, Other Intellectual Property - In8Bio
 
Thriumaine Pillay
No Relationships to Disclose
 
Samantha Youngblood
Employment - In8Bio
 
Mariska ter Haak
Employment - Axogen; IN8bio
Consulting or Advisory Role - Axogen; IN8Bio
 
Trishna Goswami
Employment - In8Bio
Leadership - In8Bio
Stock and Other Ownership Interests - In8Bio
Patents, Royalties, Other Intellectual Property - Patents around combinations with Trodelvy
Travel, Accommodations, Expenses - Immunomedics/Gilead; In8bio